Outcomes of Unilateral Cataracts in Infants and Toddlers 7 to 24 Months of Age: Toddler Aphakia and Pseudophakia Study (TAPS).


Journal

Ophthalmology
ISSN: 1549-4713
Titre abrégé: Ophthalmology
Pays: United States
ID NLM: 7802443

Informations de publication

Date de publication:
08 2019
Historique:
received: 20 11 2018
revised: 28 02 2019
accepted: 08 03 2019
pubmed: 19 3 2019
medline: 5 3 2020
entrez: 19 3 2019
Statut: ppublish

Résumé

To evaluate outcomes of unilateral cataract surgery in children 7 to 24 months of age. Retrospective case series at 10 Infant Aphakia Treatment Study (IATS) sites. The Toddler Aphakia and Pseudophakia Study is a registry of children treated by surgeons who participated in the IATS. Children underwent unilateral cataract surgery with or without intraocular lens (IOL) placement during the IATS enrollment years of 2004 and 2010. Intraoperative complications, adverse events (AEs), visual acuity, and strabismus. Fifty-six children were included with a mean postoperative follow-up of 47.6 months. Median age at cataract surgery was 13.9 months (range, 7.2-22.9). Ninety-two percent received a primary IOL. Intraoperative complications occurred in 4 patients (7%). At 5 years of age, visual acuity of treated eyes was very good (≥20/40) in 11% and poor (≤20/200) in 44%. Adverse events were identified in 24%, with a 4% incidence of glaucoma suspect. An additional unplanned intraocular surgery occurred in 14% of children. Neither AEs nor intraocular reoperations were more common for children with surgery at 7 to 12 months of age than for those who underwent surgery at 13 to 24 months of age (AE rate, 21% vs. 25% [P = 0.60]; reoperation rate, 13% vs. 16% [P = 1.00]). Although most children underwent IOL implantation concurrent with unilateral cataract removal, the incidence of complications, reoperations, and glaucoma was low when surgery was performed between 7 and 24 months of age and compared favorably with same-site IATS data for infants undergoing surgery before 7 months of age. Our study showed that IOL implantation is relatively safe in children older than 6 months and younger than 2 years.

Identifiants

pubmed: 30880109
pii: S0161-6420(18)33071-9
doi: 10.1016/j.ophtha.2019.03.011
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1189-1195

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR000135
Pays : United States

Investigateurs

Scott Lambert (S)
Amy Hutchinson (A)
Stephen Christiansen (S)
Erick Bothun (E)
Ed Wilson (E)
Elias Traboulsi (E)
David Plager (D)
Daniel Neely (D)
Deborah Vanderveen (D)
Ed Buckley (E)
Sharon Freedman (S)
David Wallace (D)
Kimberly Yen (K)
David Wheeler (D)
David Morrison (D)

Informations de copyright

Copyright © 2019 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Auteurs

Erick D Bothun (ED)

Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota; Department of Ophthalmology and Visual Neurosciences, University of Minnesota, Minneapolis, Minnesota. Electronic address: Bothun.Erick@mayo.edu.

M Edward Wilson (ME)

Storm Eye Institute, Medical University of South Carolina, Charleston, South Carolina.

Elias I Traboulsi (EI)

Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio.

Nancy N Diehl (NN)

Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota.

David A Plager (DA)

Indiana University School of Medicine, Indianapolis, Indiana.

Deborah K Vanderveen (DK)

Harvard University, Boston, Massachusetts.

Sharon F Freedman (SF)

Departments of Ophthalmology and Pediatrics, Duke University School of Medicine, Durham, North Carlina.

Kimberly G Yen (KG)

Departments of Ophthalmology and Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas.

Natalie C Weil (NC)

Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia.

Allison R Loh (AR)

Department of Ophthalmology, Oregon Health and Science University, Portland, Oregon.

David Morrison (D)

Department of Ophthalmology and Visual Sciences, Vanderbilt University Medical Center, Nashville, Tennessee.

Jill S Anderson (JS)

Department of Ophthalmology and Visual Neurosciences, University of Minnesota, Minneapolis, Minnesota.

Scott R Lambert (SR)

Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia; Departments of Ophthalmology and Pediatrics, Stanford University Medical Center, Palo Alto, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH